What does Pharmacie BOLLY do?

Pharmacie BOLLY is a pharmacy in Welkenraedt. Public Limited, started on 1 January 1984, 2 establishments.

What is the address of Pharmacie BOLLY?

The registered office of Pharmacie BOLLY is located at Village 48, 4841 Welkenraedt.

Is Pharmacie BOLLY still active?

Yes. According to the CBE (30 October 2026) Pharmacie BOLLY is active, legal situation “Normale toestand”, started on 1 January 1984.

Is Pharmacie BOLLY registered on Peppol?

Yes, Pharmacie BOLLY is registered on the Peppol network with ID 0208:0425037172.

What is the enterprise number of Pharmacie BOLLY?

The enterprise number of Pharmacie BOLLY is BE0425037172.

When was Pharmacie BOLLY founded?

Pharmacie BOLLY was founded on 1 January 1984.

Who are the directors of Pharmacie BOLLY?

According to the 2025 annual accounts, the directors of Pharmacie BOLLY are: FERME SAINT GEORGES SA, Bonaphar SRL, Nicole Falla.

Is Pharmacie BOLLY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1984; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account; 2 establishments in the CBE.

How much profit did Pharmacie BOLLY make in 2025?

Pharmacie BOLLY posted a profit after taxes of € 135,781 in financial year 2025.

What is the revenue of Pharmacie BOLLY?

As a small company, Pharmacie BOLLY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 652,181.

How much does an employee at Pharmacie BOLLY earn?

The average wage cost per full-time employee at Pharmacie BOLLY was € 61,700 in 2025: staff costs of € 345,570 for 5.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie BOLLY have?

According to the 2025 annual accounts, Pharmacie BOLLY has 5.6 full-time equivalents (FTE).

Pharmacie BOLLY (Public Limited) - Welkenraedt

Dossier Pharmacie BOLLY, printed on 30 October 2026 from databakkes.be/en/0425037172/pharmacie-bolly. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie BOLLY from Welkenraedt, company number BE0425037172, closed financial year 2025 with a result of € 135,781 after tax. For that financial year Pharmacie BOLLY recorded a gross margin of € 652,181 and equity of € 757,252. Compared with financial year 2024, the result moved from € 112,863 to € 135,781. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 11, 2026.

What it is worth Growing

€ 757,252

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 135,781

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 367,647

▲ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 75,000 paid out

55 % of the profit went to the shareholders, mostly to BONAPHAR (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

5.6

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 345,570

▲ 10% vs 2024

€ 61,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 12,316

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 420,208

▼ 15% vs 2024

€ 75,137 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 116,872

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 91,390

▲ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 508,020 Gross margin 2022: € 508,020 First fiscal year in the series	€ 520,384 Gross margin 2023: € 520,384 ▲ 2% vs 2022 (€ 508,020) Favourable step	€ 609,536 Gross margin 2024: € 609,536 ▲ 17% vs 2023 (€ 520,384) Favourable step	€ 652,181 Gross margin 2025: € 652,181 ▲ 7% vs 2024 (€ 609,536) Favourable step	▲ 7%
Profit after taxes	€ 154,823 Profit after taxes 2022: € 154,823 First fiscal year in the series	€ 57,953 Profit after taxes 2023: € 57,953 ▼ 63% vs 2022 (€ 154,823) Unfavourable step	€ 112,863 Profit after taxes 2024: € 112,863 ▲ 95% vs 2023 (€ 57,953) Favourable step	€ 135,781 Profit after taxes 2025: € 135,781 ▲ 20% vs 2024 (€ 112,863) Favourable step	▲ 20%
Equity	€ 556,330 Equity 2022: € 556,330 First fiscal year in the series	€ 600,286 Equity 2023: € 600,286 ▲ 8% vs 2022 (€ 556,330) Favourable step	€ 704,410 Equity 2024: € 704,410 ▲ 17% vs 2023 (€ 600,286) Favourable step	€ 757,252 Equity 2025: € 757,252 ▲ 8% vs 2024 (€ 704,410) Favourable step	▲ 8%
Total debts	€ 1,116,116 Total debts 2022: € 1,116,116 First fiscal year in the series	€ 908,883 Total debts 2023: € 908,883 ▼ 19% vs 2022 (€ 1,116,116) Favourable step	€ 788,271 Total debts 2024: € 788,271 ▼ 13% vs 2023 (€ 908,883) Favourable step	€ 781,169 Total debts 2025: € 781,169 ▼ 1% vs 2024 (€ 788,271) Favourable step	▼ 1%
Cash	€ 476,769 Cash 2022: € 476,769 First fiscal year in the series	€ 281,276 Cash 2023: € 281,276 ▼ 41% vs 2022 (€ 476,769) Unfavourable step	€ 290,094 Cash 2024: € 290,094 ▲ 3% vs 2023 (€ 281,276) Favourable step	€ 367,647 Cash 2025: € 367,647 ▲ 27% vs 2024 (€ 290,094) Favourable step	▲ 27%
Land & buildings	€ 615,184 Land & buildings 2022: € 615,184 First fiscal year in the series	€ 645,435 Land & buildings 2023: € 645,435 ▲ 5% vs 2022 (€ 615,184) Unchanged	€ 575,015 Land & buildings 2024: € 575,015 ▼ 11% vs 2023 (€ 645,435) Unchanged	€ 496,277 Land & buildings 2025: € 496,277 ▼ 14% vs 2024 (€ 575,015) Unchanged	▼ 14%
Retained profit	€ 329,330 Retained profit 2022: € 329,330 First fiscal year in the series	€ 373,286 Retained profit 2023: € 373,286 ▲ 13% vs 2022 (€ 329,330) Favourable step	€ 477,410 Retained profit 2024: € 477,410 ▲ 28% vs 2023 (€ 373,286) Favourable step	€ 530,252 Retained profit 2025: € 530,252 ▲ 11% vs 2024 (€ 477,410) Favourable step	▲ 11%
Dividend	€ 110,000 Dividend 2022: € 110,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 110,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 75,000 Dividend 2025: € 75,000 Unchanged (€ 0) Unchanged
Bank debt	€ 562,202 Bank debt 2022: € 562,202 First fiscal year in the series	€ 566,179 Bank debt 2023: € 566,179 ▲ 1% vs 2022 (€ 562,202) Unfavourable step	€ 493,910 Bank debt 2024: € 493,910 ▼ 13% vs 2023 (€ 566,179) Favourable step	€ 420,208 Bank debt 2025: € 420,208 ▼ 15% vs 2024 (€ 493,910) Favourable step	▼ 15%
Balance sheet total	€ 1,672,446 Balance sheet total 2022: € 1,672,446 First fiscal year in the series	€ 1,509,169 Balance sheet total 2023: € 1,509,169 ▼ 10% vs 2022 (€ 1,672,446) Unchanged	€ 1,492,681 Balance sheet total 2024: € 1,492,681 ▼ 1% vs 2023 (€ 1,509,169) Unchanged	€ 1,538,421 Balance sheet total 2025: € 1,538,421 ▲ 3% vs 2024 (€ 1,492,681) Unchanged	▲ 3%
Employees (FTE)	5.2 Employees (FTE) 2022: 5.2 First fiscal year in the series	5.4 Employees (FTE) 2023: 5.4 ▲ 0.2 vs 2022 (5.2) Unchanged	5.7 Employees (FTE) 2024: 5.7 ▲ 0.3 vs 2023 (5.4) Unchanged	5.6 Employees (FTE) 2025: 5.6 ▼ 0.1 vs 2024 (5.7) Unchanged	▼ 0.1

Key figures of Pharmacie BOLLY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmacie BOLLY?

What happened at Pharmacie BOLLY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 FERME SAINT GEORGES SA stepped down as director. NBB
2029 Bonaphar SRL stepped down as director. NBB
2029 Nicole Falla stepped down as director. NBB
Jul 11, 2026 New annual accounts for financial year 2025: profit of € 135,781 (▲ 20% vs 2024). Source: NBB ↗
2023 FERME SAINT GEORGES SA became a director. NBB
2023 Bonaphar SRL became a director. NBB
2023 Nicole Falla became a director. NBB
Jul 1, 2010 New establishment in Plombières. KBO

In short

From € 154,823 profit in 2022 to € 135,781 profit in 2025.

Paid € 93,022 in corporate taxes since 2022.

Best year ever: 2022, with € 154,823 profit.

On average € 116,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BONAPHAR 100%

The stake of BONAPHAR comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Pharmacie BOLLY

The shares are held by BONAPHAR (100%).

Directors

According to the 2025 annual accounts

FERME SAINT GEORGES SA

Director · represented by Richard Bolly

since 2023 · until 2029

Bonaphar SRL

Managing director · represented by Nathalie Bolly

Also active at: FERME SAINT GEORGES

since 2023 · until 2029

Nicole Falla

Director

Also active at: FERME SAINT GEORGES

since 2023 · until 2029

Shareholders

BONAPHAR

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Village 48

4841 Welkenraedt

2.313.185.229

Centre 81

4852 Plombières

Active since 1 July 2010

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Dr Gregory Ernst

€ 237,429 gross margin · 2025

BONAPHAR same network

€ -20,914 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0425.037.172

VAT number

BE 0425.037.172

Registered office

Village 48, 4841 Welkenraedt

Names & denominations

Pharmacie BOLLY

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

1 January 1984

Peppol

Active · Active since 13 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Pharmacie BOLLY

Financials

What happened to Pharmacie BOLLY?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions